Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

20.13
Delayed Data
As of Apr 24
 +0.04 / +0.20%
Today’s Change
9.38
Today|||52-Week Range
20.43
+67.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

Momenta Pharmaceuticals, Inc. is a biotechnology company, engages in the structural analysis of complex mixture drugs. The company focuses on discovering and developing medicines in three product areas: complex generics, biosimilars and novel therapeutics for oncology and autoimmune disease. The three product areas correspond with their respective regulatory pathways. the Company views its business as one reportable operating segment-the discovery, development and commercialization of pharmaceutical products. Momenta Pharmaceuticals was founded by Ram Sasisekharan and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Contact Information

Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge Massachusetts 02142
P:(617) 491-9700
Investor Relations:
(617) 395-5189

Employees

Shareholders

Other institutional46.54%
Mutual fund holders46.21%
Individual stakeholders25.49%

Top Executives

Craig A. WheelerPresident, Chief Executive Officer & Director
Richard P. SheaChief Financial Officer & Senior Vice President
Ganesh Kaundinya VenkataramanChief Scientific Officer & Senior VP-Research
James M. RoachChief Medical Officer & Senior VP-Development
Bruce A. LeicherSecretary, Senior VP & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account